Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Drew

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Practice|June 17, 2011
Application of antimicrobial stewardship to optimise management of community acquired pneumoniaJ A Bosso, R H Drew
Pharmacotherapy|January 1, 1988
Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical applicationR H Drew, H A Gallis
Otolaryngologic Clinics of North America|March 29, 2000
Agents for treatment of invasive fungal infectionsB Luna, R H Drew, J R Perfect
Clinical Pharmacy|August 1, 1988
Use of fluconazole in a patient with documented malabsorption of ketoconazoleR H Drew, J R Perfect, H A Gallis
Journal of Clinical Pharmacy and Therapeutics|January 29, 2013
How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable?S W Johnson, R H Drew, D B May
Reviews of Infectious Diseases|March 1, 1990
Amphotericin B: 30 years of clinical experienceH A Gallis, R H Drew, W W Pickard
Pharmacotherapy|October 3, 1998
Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literatureM D Johnson, R H Drew, J R Perfect
Pharmacotherapy|July 1, 1996
Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristinR E Fuller, R H Drew, J R Perfect
Drug Safety|September 1, 1992
Adverse drug reactions to systemic antifungals. Prevention and managementJ R Perfect, M H Lindsay, R H Drew
Pharmacotherapy|November 18, 2000
Antifungal pharmacodynamics: review of the literature and clinical applicationsE S Dodds, R H Drew, J R Perfect
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Practice|June 17, 2011
Application of antimicrobial stewardship to optimise management of community acquired pneumoniaJ A Bosso, R H Drew
Pharmacotherapy|January 1, 1988
Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical applicationR H Drew, H A Gallis
Otolaryngologic Clinics of North America|March 29, 2000
Agents for treatment of invasive fungal infectionsB Luna, R H Drew, J R Perfect
Clinical Pharmacy|August 1, 1988
Use of fluconazole in a patient with documented malabsorption of ketoconazoleR H Drew, J R Perfect, H A Gallis
Journal of Clinical Pharmacy and Therapeutics|January 29, 2013
How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable?S W Johnson, R H Drew, D B May
Reviews of Infectious Diseases|March 1, 1990
Amphotericin B: 30 years of clinical experienceH A Gallis, R H Drew, W W Pickard
Pharmacotherapy|October 3, 1998
Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literatureM D Johnson, R H Drew, J R Perfect
Pharmacotherapy|July 1, 1996
Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristinR E Fuller, R H Drew, J R Perfect
Drug Safety|September 1, 1992
Adverse drug reactions to systemic antifungals. Prevention and managementJ R Perfect, M H Lindsay, R H Drew
Pharmacotherapy|November 18, 2000
Antifungal pharmacodynamics: review of the literature and clinical applicationsE S Dodds, R H Drew, J R Perfect
Pageof 4